Is G-Ba Strategically Discounting The Benefit Assessment of Relatively High Cost Drugs?

Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1179
https://www.valueinhealthjournal.com/article/S1098-3015(14)03109-X/fulltext
Title : Is G-Ba Strategically Discounting The Benefit Assessment of Relatively High Cost Drugs?
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03109-X&doi=10.1016/j.jval.2014.08.1179
First page : A444
Section Title : Health Care Use and Policy Studies
Open access? : No
Section Order : 671
Categories :
Tags :
Regions :
ViH Article Tags :